Fusions involving BCOR and CREBBP are rare events in infiltrating glioma

Table 1 Summary of molecular data interrogated by Oncomine, PCR and immunohistochemistry

POSITIVE CALLS	PERTINENT NEGATIVES
ARID1A p.Asp204fs	mutations in IDH1, IDH2
TERT promoter mutation c.-124C > T	H3 K27M and G34 by IHC and PCR/Sanger
NF1 p.Trp696Ter	EGFR amplification
ATRX loss of expression by IHC	Remaining Oncomine Panel Targets^a

Next generation sequencing using the Oncomine® panel v3. Positive calls are listed in the left column while selected pertinent negatives are listed in the right column
^aSee Supplementary Table 1 for a complete list of genes interrogated by the Oncomine panel

ISSN: 2051-5960